Tumour-suppressor microRNAs let-7 and mir-101 target the proto-oncogene MYCN and inhibit cell proliferation in MYCN-amplified neuroblastoma

被引:165
作者
Buechner, J. [1 ,2 ]
Tomte, E. [2 ]
Haug, B. H. [2 ]
Henriksen, J. R. [2 ]
Lokke, C. [2 ]
Flaegstad, T. [1 ,2 ]
Einvik, C. [1 ,2 ]
机构
[1] Univ Hosp N Norway, Dept Paediat, N-9038 Tromso, Norway
[2] Univ Tromso, Fac Hlth Sci, Dept Clin Med, Paediat Res Grp, N-9037 Tromso, Norway
关键词
neuroblastoma; N-myc; MYCN; let-7; mir-101; 3 ' UTR; NEURONAL DIFFERENTIATION; N-MYC; CANCER; EXPRESSION; ONCOPROTEIN; MOLECULE; OVEREXPRESSION; REPRESSES; APOPTOSIS; PATHWAYS;
D O I
10.1038/bjc.2011.220
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: MicroRNAs (miRNAs) regulate expression of many cancer-related genes through posttranscriptional repression of their mRNAs. In this study we investigate the proto-oncogene MYCN as a target for miRNA regulation. METHODS: A luciferase reporter assay was used to investigate software-predicted miRNA target sites in the 3'-untranslated region (3'UTR) of MYCN. The miRNAs were overexpressed in cell lines by transfection of miRNA mimics or miRNA-expressing plasmids. Mutation of the target sites was used to validate MYCN 3'UTR as a direct target of several miRNAs. To measure miRNA-mediated suppression of endogenous N-myc protein, inhibition of proliferation and inhibition of clonogenic growth, miRNAs were overexpressed in a MYCN-amplified neuroblastoma cell line. RESULTS: The results from this study show that MYCN is targeted by several miRNAs. In addition to the previously shown mir-34a/c, we experimentally validate mir-449, mir-19a/b, mir-29a/b/c, mir-101 and let-7e/mir-202 as direct MYCN-targeting miRNAs. These miRNAs were able to suppress endogenous N-myc protein in a MYCN-amplified neuroblastoma cell line. The let-7e and mir-202 were strong negative regulators of MYCN expression. The mir-101 and the let-7 family miRNAs let-7e and mir-202 inhibited proliferation and clonogenic growth when overexpressed in Kelly cells. CONCLUSION: The tumour-suppressor miRNAs let-7 and mir-101 target MYCN and inhibit proliferation and clonogenic growth of MYCN-amplified neuroblastoma cells. British Journal of Cancer (2011) 105, 296-303. doi: 10.1038/bjc.2011.220 www.bjcancer.com Published online 7 June 2011 (C) 2011 Cancer Research UK
引用
收藏
页码:296 / 303
页数:8
相关论文
共 54 条
[1]   let-7 microRNA functions as a potential growth suppressor in human colon cancer cells [J].
Akao, Yukihiro ;
Nakagawa, Yoshihito ;
Naoe, Tomoki .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2006, 29 (05) :903-906
[2]   MYC in Oncogenesis and as a Target for Cancer Therapies [J].
Albihn, Ami ;
Johnsen, John Inge ;
Henriksson, Marie Arsenian .
ADVANCES IN CANCER RESEARCH, VOL 107, 2010, 107 :163-224
[3]   Chromosome 1p and 11q deletions and outcome in neuroblastoma [J].
Attiyeh, EF ;
London, WB ;
Mossé, YP ;
Wang, Q ;
Winter, C ;
Khazi, D ;
McGrady, PW ;
Seeger, RC ;
Look, AT ;
Shimada, H ;
Brodeur, GM ;
Cohn, SL ;
Matthay, KK ;
Maris, JM .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (21) :2243-2253
[4]   MYCN oncoprotein targets and their therapeutic potential [J].
Bell, Emma ;
Chen, Lindi ;
Liu, Tao ;
Marshall, Glenn M. ;
Lunec, John ;
Tweddle, Deborah A. .
CANCER LETTERS, 2010, 293 (02) :144-157
[5]   Inhibition of mir-21, which is up-regulated during MYCN knockdown-mediated differentiation, does not prevent differentiation of neuroblastoma cells [J].
Buechner, Jochen ;
Henriksen, Jorn R. ;
Haug, Bjorn Helge ;
Tomte, Ellen ;
Flaegstad, Trond ;
Einvik, Christer .
DIFFERENTIATION, 2011, 81 (01) :25-34
[6]   MicroRNA-101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF-1α/HIF-1β [J].
Cao, Paul ;
Deng, Zhiyong ;
Wan, Meimei ;
Huang, Weiwei ;
Cramer, Scott D. ;
Xu, Jianfeng ;
Lei, Ming ;
Sui, Guangchao .
MOLECULAR CANCER, 2010, 9
[7]   Identification of 41g-B7-H3 as a neuroblastoma-associated molecule that exerts a protective role from an NK cell-mediated lysis [J].
Castriconi, R ;
Dondero, A ;
Augugliaro, R ;
Cantoni, C ;
Carnemolla, B ;
Sementa, AR ;
Negri, F ;
Conte, R ;
Corrias, MV ;
Moretta, L ;
Moretta, A ;
Bottino, C .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (34) :12640-12645
[8]   MYCN expression is not prognostic of adverse outcome in advanced-stage neuroblastoma with nonamplified MYCN [J].
Cohn, SL ;
London, WB ;
Huang, DH ;
Katzenstein, HM ;
Salwen, HR ;
Reinhart, T ;
Madafiglio, J ;
Marshall, GM ;
Norris, MD ;
Haber, M .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (21) :3604-3613
[9]   A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene [J].
Cole, Kristina A. ;
Attiyeh, Edward F. ;
Mosse, Yael P. ;
Laquaglia, Michael J. ;
Diskin, Sharon J. ;
Brodeur, Garrett M. ;
Maris, John M. .
MOLECULAR CANCER RESEARCH, 2008, 6 (05) :735-742
[10]   Specificity of microRNA target selection in translational repression [J].
Doench, JG ;
Sharp, PA .
GENES & DEVELOPMENT, 2004, 18 (05) :504-511